Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as a injectable solution for intravenous use. It treats acid‑related disorders such as erosive esophagitis, gastric and duodenal ulcers, provides ulcer prophylaxis, and is used for Zollinger‑Ellison syndrome and stress‑related mucosal damage in hospitalized patients.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor used to manage conditions associated with excess gastric acid secretion. - Erosive esophagitis: reduces acid exposure to promote healing of the esophageal lining. - Gastric ulcer: accelerates ulcer healing by suppressing gastric acid production. - Duodenal ulcer: facilitates mucosal repair through sustained acid suppression. - NSAID‑induced ulcer prophylaxis: prevents ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs. - Zollinger‑Ellison syndrome: controls hypergastrinemia‑driven acid hypersecretion. - Stress‑related mucosal damage in critically ill patients: provides rapid acid control to reduce risk of stress ulcers.

Common Side Effects: - Headache: mild to moderate pain often reported during therapy. - Diarrhea: loose stools may occur, usually transient. - Nausea: feeling of queasiness without vomiting. - Abdominal pain: discomfort or cramping in the stomach area. - Injection site reactions: redness, swelling, or mild pain at the IV site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Serum magnesium decrease: hypomagnesemia leading to muscle cramps or arrhythmia. - Hepatic enzyme elevation: increased ALT/AST indicating liver stress. - Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement.

Before initiating therapy, consider the following precautions: - Renal impairment: monitor renal function and adjust dosing if necessary. - Hepatic impairment: use with caution in patients with liver disease. - Elderly patients: observe for electrolyte disturbances, especially magnesium. - Concurrent antacids: avoid simultaneous IV administration to prevent incompatibility. - Pregnancy: safety not established; prescribe only when benefit outweighs risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Pantoprazole may interact with several medications; review patient medication lists carefully. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to subtherapeutic antiviral levels. - Warfarin: potential increase in INR and bleeding risk. Moderate Interactions (Monitor Closely): - Methotrexate: reduced renal clearance may raise serum concentrations. - Digoxin: possible increase in serum digoxin levels. - Diazepam: may experience elevated plasma concentrations.